Nicotinamide dependence of uropathogenic Escherichia coli UTI89 and application of nadB as a neutral insertion site

Microbiology

Volumn 158, Issue 3, 2012, Pages 736-745

  Li, Zhaoli ^a,b   Bouckaert, Julie ^a,c   Deboeck, Francine ^a   de Greve, Henri ^a,d   Hernalsteens, Jean Pierre ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b HVRI   (China)

^c UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

^d DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE OXIDASE; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; QUINOLINIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUXOTROPHY; BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIAL VIRULENCE; CONTROLLED STUDY; CYSTITIS; ESCHERICHIA COLI K 12; GENE INSERTION; GENE MUTATION; MOUSE; NADA GENE; NADB GENE; NADC GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SHIGELLA; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

AMINO ACID SUBSTITUTION; ANIMALS; DISEASE MODELS, ANIMAL; DNA, BACTERIAL; FEMALE; GENETIC COMPLEMENTATION TEST; HUMANS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED CBA; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; MUTANT PROTEINS; NIACINAMIDE; POINT MUTATION; QUINOLINIC ACID; SEQUENCE ANALYSIS, DNA; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; ESCHERICHIA COLI K12; MURINAE; SHIGELLA;

EID: 84863287000     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.052043-0     Document Type: Article

References (43)

1. Achtman, M., Mercer, A., Kusecek, B., Pohl, A., Heuzenroeder, M., Aaronson, W., Sutton, A. & Silver, R. P. (1983). Six widespread bacterial clones among Escherichia coli K1 isolates. Infect Immun 39, 315-335.
2. Bahrani-Mougeot, F. K., Buckles, E. L., Lockatell, C. V., Hebel, J. R., Johnson, D. E., Tang, C. M. & Donnenberg, M. S. (2002). Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract. Mol Microbiol 45, 1079-1093.
3. Bergthorsson, U. & Roth, J. R. (2005). Natural isolates of Salmonella enterica serovar Dublin carry a single nadA missense mutation. J Bacteriol 187, 400-403.
4. Beuzón, C. R. & Holden, D. W. (2001). Use of mixed infections with Salmonella strains to study virulence genes and their interactions in vivo. Microbes Infect 3, 1345-1352.
5. Bossi, R. T., Negri, A., Tedeschi, G. & Mattevi, A. (2002). Structure of FAD-bound L-aspartate oxidase: insight into substrate specificity and catalysis. Biochemistry 41, 3018-3024.
6. Chen, S. L., Hung, C. S., Xu, J., Reigstad, C. S., Magrini, V., Sabo, A., Blasiar, D., Bieri, T., Meyer, R. R. & other authors (2006). Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: a comparative genomics approach. Proc Natl Acad Sci U S A 103, 5977-5982.
7. Choi, K. H. & Schweizer, H. P. (2006). Mini-Tn7 insertion in bacteria with single attTn7 sites: example Pseudomonas aeruginosa. Nat Protoc 1, 153-161.
8. Colson, C., Glover, S. W., Symonds, N. & Stacey, K. A. (1965). The location of the genes for host-controlled modification and restriction in Escherichia coli K-12. Genetics 52, 1043-1050.
9. Craig, N. L. (1991). Tn7: a target site-specific transposon. Mol Microbiol 5, 2569-2573.
10. Cusumano, C. K., Hung, C. S., Chen, S. L. & Hultgren, S. J. (2010). Virulence plasmid harbored by uropathogenic Escherichia coli functions in acute stages of pathogenesis. Infect Immun 78, 1457-1467.
11. Datsenko, K. A. & Wanner, B. L. (2000). One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97, 6640-6645.
12. Emori, T. G. & Gaynes, R. P. (1993). An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 6, 428-442.
13. Hannan, T. J., Mysorekar, I. U., Hung, C. S., Isaacson-Schmid, M. L. & Hultgren, S. J. (2010). Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog 6, e1001042.
14. Hochhut, B., Wilde, C., Balling, G., Middendorf, B., Dobrindt, U., Brzuszkiewicz, E., Gottschalk, G., Carniel, E. & Hacker, J. (2006). Role of pathogenicity island-associated integrases in the genome plasticity of uropathogenic Escherichia coli strain 536. Mol Microbiol 61, 584-595.
15. Holden, N. J., Totsika, M., Mahler, E., Roe, A. J., Catherwood, K., Lindner, K., Dobrindt, U. & Gally, D. L. (2006). Demonstration of regulatory cross-talk between P fimbriae and type 1 fimbriae in uropathogenic Escherichia coli. Microbiology 152, 1143-1153.
16. Hull, R. A. & Hull, S. I. (1997). Nutritional requirements for growth of uropathogenic Escherichia coli in human urine. Infect Immun 65, 1960-1961.
17. Hung, C. S., Dodson, K. W. & Hultgren, S. J. (2009). A murine model of urinary tract infection. Nat Protoc 4, 1230-1243.
18. Justice, S. S., Hung, C., Theriot, J. A., Fletcher, D. A., Anderson, G. G., Footer, M. J. & Hultgren, S. J. (2004). Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc Natl Acad Sci U S A 101, 1333-1338.
19. Kao, J. S., Stucker, D. M., Warren, J. W. & Mobley, H. L. (1997). Pathogenicity island sequences of pyelonephritogenic Escherichia coli CFT073 are associated with virulent uropathogenic strains. Infect Immun 65, 2812-2820.
20. Kulesus, R. R., Diaz-Perez, K., Slechta, E. S., Eto, D. S. & Mulvey, M. A. (2008). Impact of the RNA chaperone Hfq on the fitness and virulence potential of uropathogenic Escherichia coli. Infect Immun 76, 3019-3026.
21. Kunin, C. M., Hua, T. H., Krishnan, C., Van Arsdale White, L. & Hacker, J. (1993). Isolation of a nicotinamide-requiring clone of Escherichia coli O18:K1:H7 fromwomen with acute cystitis: resemblance to strains found in neonatal meningitis. Clin Infect Dis 16, 412-416.
22. Lan, R., Alles, M. C., Donohoe, K., Martinez, M. B. & Reeves, P. R. (2004). Molecular evolutionary relationships of enteroinvasive Escherichia coli and Shigella spp. Infect Immun 72, 5080-5088.
23. Lane, M. C., Alteri, C. J., Smith, S. N. & Mobley, H. L. (2007). Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc Natl Acad Sci U S A 104, 16669-16674.
24. Mantis, N. J. & Sansonetti, P. J. (1996). The nadB gene of Salmonella typhimurium complements the nicotinic acid auxotrophy of Shigella flexneri. Mol Gen Genet 252, 626-629.
25. Miller, J. H. (1992). A short course in bacterial genetics: a laboratory manual and handbook for Escherichia coli and related bacteria. Plainview, NY: Cold Spring Harbor Laboratory.
26. Mulvey, M. A., Schilling, J. D. & Hultgren, S. J. (2001). Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun 69, 4572-4579.
27. Nimmich, W. & Zingler, G. (1984). Biochemical characteristics, phage patterns, and O1 factor analysis of Escherichia coli O1:K1:H7:F11 and O1:K1:H-:F9 strains isolated from patients with urinary tract infections. Med Microbiol Immunol (Berl) 173, 75-85.
28. Ochman, H. & Davalos, L. M. (2006). The nature and dynamics of bacterial genomes. Science 311, 1730-1733.
29. Osterman, A. (2002). Escherichia coli and Salmonella: cellular and molecular biology. Edited by T. Begley. Washington, DC: American Society for Microbiology.
30. Pattery, T., Hernalsteens, J. P. & De Greve, H. (1999). Identification and molecular characterization of a novel Salmonella enteritidis pathogenicity islet encoding an ABC transporter. Mol Microbiol 33, 791-805.
31. Prunier, A. L., Schuch, R., Fernández, R. E. & Maurelli, A. T. (2007a). Genetic structure of the nadA and nadB antivirulence loci in Shigella spp. J Bacteriol 189, 6482-6486.
32. Prunier, A. L., Schuch, R., Fernández, R. E., Mumy, K. L., Kohler, H., McCormick, B. A. & Maurelli, A. T. (2007b). nadA and nadB of Shigella flexneri 5a are antivirulence loci responsible for the synthesis of quinolinate, a small molecule inhibitor of Shigella pathogenicity. Microbiology 153, 2363-2372.
33. Purich, D. L. & Allison, R. D. (2002). The enzyme reference: a comprehensive guidebook to enzyme nomenclature, reactions, and methods. San Diego, CA: Academic Press.
34. Reed, J. L., Vo, T. D., Schilling, C. H. & Palsson, B. O. (2003). An expanded genome-scale model of Escherichia coli K-12 (iJR904 GSM/GPR). Genome Biol 4, R54.
35. Rosen, D. A., Hung, C. S., Kline, K. A. & Hultgren, S. J. (2008). Streptozocin-induced diabetic mouse model of urinary tract infection. Infect Immun 76, 4290-4298.
36. Russo, T. A., Jodush, S. T., Brown, J. J. & Johnson, J. R. (1996). Identification of two previously unrecognized genes (guaA and argC) important for uropathogenesis. Mol Microbiol 22, 217-229.
37. Simon, R., Priefer, U. & Pühler, A. (1983). A broad host range mobillization system for in vivo genetic engineering: transposon mutagenesis in gram negative bacteria. Nature Biotechnology 1, 784-791.
38. Stokes, J. L. & Bayne, H. G. (1958). Growth-factor-dependent strains of Salmonellae. J Bacteriol 76, 417-421.
39. Tedeschi, G., Ronchi, S., Simonic, T., Treu, C., Mattevi, A. & Negri, A. (2001). Probing the active site of L-aspartate oxidase by site-directed mutagenesis: role of basic residues in fumarate reduction. Biochemistry 40, 4738-4744.
40. Welch, R. A., Burland, V., Plunkett, G., III, Redford, P., Roesch, P., Rasko, D., Buckles, E. L., Liou, S. R., Boutin, A. & other authors (2002). Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci U S A 99, 17020-17024.
41. Wiles, T. J., Bower, J. M., Redd, M. J. & Mulvey, M. A. (2009). Use of zebrafish to probe the divergent virulence potentials and toxin requirements of extraintestinal pathogenic Escherichia coli. PLoS Pathog 5, e1000697.
42. Woodcock, D. M., Crowther, P. J., Doherty, J., Jefferson, S., DeCruz, E., Noyer-Weidner, M., Smith, S. S., Michael, M. Z. & Graham, M. W. (1989). Quantitative evaluation of Escherichia coli host strains for tolerance to cytosine methylation in plasmid and phage recombinants. Nucleic Acids Res 17, 3469-3478.
43. You, K. S. & Oppenheimer, N. J. (1985). Stereospecificity for nicotinamide nucleotides in enzymatic and chemical hydride transfer reactions. CRC Crit Rev Biochem 17, 313-451.